RECURRENT GLIOSARCOMA
Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test genetically supercharged immune cells against deadly brain tumor
Disease control Recruiting nowThis is a first-in-human study testing a new type of cell therapy for glioblastoma that has returned after treatment. Doctors are giving patients genetically modified immune cells, called NK cells, directly into the brain to see if they can attack the cancer. The main goals are t…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Two-Pronged attack on deadly brain cancer
Disease control Recruiting nowThis study is testing a combination of two drugs, atezolizumab and cabozantinib, for adults with glioblastoma that has returned after initial treatment. The goal is to see if this combination is safe and can help control the cancer by boosting the immune system and blocking tumor…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hijack cold virus to target and attack deadly brain tumors
Disease control Recruiting nowThis early-stage trial is testing a new treatment for aggressive brain cancers that have returned. Doctors are using stem cells to carry a specially engineered cold virus directly to the tumor. The goal is to see if the virus can safely infect and kill the cancer cells while spar…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Double-Punch immunotherapy trial aims to extend life for deadly brain cancer patients
Disease control Recruiting nowThis study is testing whether giving two immunotherapy drugs before and after surgery can help people with glioblastoma that has returned after initial treatment. The trial will enroll 54 adults whose brain cancer has come back despite previous surgery, radiation, and chemotherap…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC